@prefix epid: <https://arxiv.universalpublishings.com/id/> .
  @prefix dc: <http://purl.org/dc/elements/1.1/> .
  @prefix event: <http://purl.org/NET/c4dm/event.owl#> .
  @prefix doi: <https://doi.org/> .
  @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
  @prefix eprel: <http://eprints.org/relation/> .
  @prefix geo: <http://www.w3.org/2003/01/geo/wgs84_pos#> .
  @prefix foaf: <http://xmlns.com/foaf/0.1/> .
  @prefix skos: <http://www.w3.org/2004/02/skos/core#> .
  @prefix void: <http://rdfs.org/ns/void#> .
  @prefix dct: <http://purl.org/dc/terms/> .
  @prefix ep: <http://eprints.org/ontology/> .
  @prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
  @prefix cc: <http://creativecommons.org/ns#> .
  @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
  @prefix owl: <http://www.w3.org/2002/07/owl#> .
  @prefix bibo: <http://purl.org/ontology/bibo/> .

<>
	foaf:primaryTopic <https://arxiv.universalpublishings.com/id/eprint/52936>;
	rdfs:comment "The repository administrator has not yet configured an RDF license."^^xsd:string .

<https://arxiv.universalpublishings.com/id/eprint/52936#authors>
	rdf:_1 <https://arxiv.universalpublishings.com/id/person/ext-4938161605d4146b226dd88c0059704d>;
	rdf:_2 <https://arxiv.universalpublishings.com/id/person/ext-b4fd9c733729bb4892f7c772fde89acc>;
	rdf:_3 <https://arxiv.universalpublishings.com/id/person/ext-5409e1ae9c66edf70634ab0e42cfab56> .

<https://arxiv.universalpublishings.com/id/eprint/52936/>
	dc:format "text/html";
	dc:title "HTML Summary of #52936 \n\nCLINICAL PHARMACOLOGY OF HYPOGLYCEMIC DRUGS\n\n";
	foaf:primaryTopic <https://arxiv.universalpublishings.com/id/eprint/52936> .

<https://arxiv.universalpublishings.com/id/eprint/52936>
	bibo:abstract "In patients with diabetes mellitus type 2, non-insulin antihyperglycemic therapy is aimed to control symptoms of hyperglycemia and to limit microvascular complications. It is introduced early after diagnosis of the disease. Antihyperglycemic agents may predominantly act through one of four ways. The involved mechanisms are: enhancement of insulin secretion, through which act sulfonylureas, meglitinides and two types of incretin mimetics - glucagon-like peptide-1 (GLP-1) receptor agonists and inhibitors of dipeptidyl peptidase-4 (DPP-4) activity -gliptins; suppression of hepatic glucose production - biguanides; enhanced sensitivity to insulin - thiazolidinediones, and decrease of the rate or extent of glucose absorption: islet amyloid polypeptide (amylin) analogs and α-glucosidase inhibitors. With exception of GLP-1 receptor agonists and pramlintide, a synthetic form of amylin, all these drugs are administered orally."^^xsd:string;
	bibo:authorList <https://arxiv.universalpublishings.com/id/eprint/52936#authors>;
	bibo:status <http://purl.org/ontology/bibo/status/published>;
	dct:creator <https://arxiv.universalpublishings.com/id/person/ext-5409e1ae9c66edf70634ab0e42cfab56>,
		<https://arxiv.universalpublishings.com/id/person/ext-4938161605d4146b226dd88c0059704d>,
		<https://arxiv.universalpublishings.com/id/person/ext-b4fd9c733729bb4892f7c772fde89acc>;
	dct:date "2024-01-20";
	dct:isPartOf <https://arxiv.universalpublishings.com/id/repository>,
		<https://arxiv.universalpublishings.com/id/publication/ext-d62a5dbdabc792c15cf76756361a4d36>;
	dct:publisher <https://arxiv.universalpublishings.com/id/org/ext-20ef1f289b7920027328009b5eefe52c>;
	dct:title "CLINICAL PHARMACOLOGY OF HYPOGLYCEMIC DRUGS"^^xsd:string;
	rdf:type bibo:AcademicArticle,
		bibo:Article,
		ep:ArticleEPrint,
		ep:EPrint;
	rdfs:seeAlso <https://arxiv.universalpublishings.com/id/eprint/52936/> .

<https://arxiv.universalpublishings.com/id/org/ext-20ef1f289b7920027328009b5eefe52c>
	foaf:name "Center for Tech and Media Research"^^xsd:string;
	rdf:type foaf:Organization .

<https://arxiv.universalpublishings.com/id/person/ext-5409e1ae9c66edf70634ab0e42cfab56>
	foaf:familyName "Yuldashevich"^^xsd:string;
	foaf:givenName "Chariev Muzaffar"^^xsd:string;
	foaf:name "Chariev Muzaffar Yuldashevich"^^xsd:string;
	rdf:type foaf:Person .

<https://arxiv.universalpublishings.com/id/person/ext-4938161605d4146b226dd88c0059704d>
	foaf:familyName "o'g'li"^^xsd:string;
	foaf:givenName "Rayimnazarov Shaxzot Muhiddin"^^xsd:string;
	foaf:name "Rayimnazarov Shaxzot Muhiddin o'g'li"^^xsd:string;
	rdf:type foaf:Person .

<https://arxiv.universalpublishings.com/id/person/ext-b4fd9c733729bb4892f7c772fde89acc>
	foaf:familyName "o'g'li"^^xsd:string;
	foaf:givenName "Abduraxmonov Alijon Shodmon"^^xsd:string;
	foaf:name "Abduraxmonov Alijon Shodmon o'g'li"^^xsd:string;
	rdf:type foaf:Person .

<https://arxiv.universalpublishings.com/id/publication/ext-d62a5dbdabc792c15cf76756361a4d36>
	foaf:name "Multidisciplinary Journal of Science and Technology"^^xsd:string;
	rdf:type bibo:Collection .